EPO and Parkinson disease: An additional link between EPO and metabolism comes from the observation that, in an in vitro model of Parkinson’s disease characterized by augmented redox imbalance [280], EPO accelerates the glycolytic rate without affecting the mitochondrial function, contributing to restoring in part the ATP levels in a manner similar to hypoxia adaptation [281].